Prostatic Neoplasms, Castration-Resistant trials recruiting in New York

All Prostatic Neoplasms, Castration-Resistant trials nationally

Cities in New York

Recruiting trials in New York

• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
  NCT04868604 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · New York: New York
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07225946 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Mineola, New York, The Bronx
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo, New York, Rochester, The Bronx
• Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
  NCT05743621 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · New York: New York